Biohaven Ltd. - BHVN
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Mar 19, 2026 | — | G | A | 17,342.0 | 0.0 | 0.0 | 17,342.0 | View | |
| Mar 19, 2026 | — | G | D | 17,342.0 | 0.0 | 0.0 | 5,320.0 | View | |
| Mar 09, 2026 | — | P | A | 28,400.0 | 30.4266 | 864,115.44 | 2,323,971.0 | View | |
| Mar 03, 2026 | Chief Scientific Officer | A | A | 175,000.0 | 0.0 | 0.0 | 175,000.0 | View | |
| Mar 03, 2026 | VP, Chief Accounting Officer | A | A | 50,000.0 | 0.0 | 0.0 | 50,000.0 | View | |
| Mar 03, 2026 | SVP, Clinical Operations | A | A | 175,000.0 | 0.0 | 0.0 | 175,000.0 | View | |
| Mar 03, 2026 | Chief Financial Officer | A | A | 175,000.0 | 0.0 | 0.0 | 175,000.0 | View | |
| Mar 03, 2026 | Chief Executive Officer | A | A | 550,000.0 | 0.0 | 0.0 | 550,000.0 | View | |
| Jan 07, 2026 | VP, Chief Accounting Officer | M | D | 2,500.0 | 0.0 | 0.0 | 5,000.0 | View | |
| Jan 07, 2026 | VP, Chief Accounting Officer | F | D | 1,117.0 | 9.93 | 11,091.81 | 66,978.0 | View | |
| Jan 07, 2026 | VP, Chief Accounting Officer | M | A | 2,500.0 | 0.0 | 0.0 | 68,095.0 | View | |
| Jan 07, 2026 | SVP, Clinical Operations | M | D | 3,750.0 | 0.0 | 0.0 | 7,500.0 | View | |
| Jan 07, 2026 | SVP, Clinical Operations | F | D | 1,956.0 | 9.93 | 19,423.08 | 99,557.0 | View | |
| Jan 07, 2026 | SVP, Clinical Operations | M | A | 3,750.0 | 0.0 | 0.0 | 101,513.0 | View | |
| Jan 07, 2026 | Chief Financial Officer | M | D | 4,250.0 | 0.0 | 0.0 | 8,500.0 | View | |
| Jan 07, 2026 | Chief Financial Officer | F | D | 2,594.0 | 9.93 | 25,758.42 | 195,652.0 | View | |
| Jan 07, 2026 | Chief Financial Officer | M | A | 4,250.0 | 0.0 | 0.0 | 198,246.0 | View | |
| Jan 07, 2026 | Chief Executive Officer | M | D | 14,250.0 | 0.0 | 0.0 | 28,500.0 | View | |
| Jan 07, 2026 | Chief Executive Officer | F | D | 7,430.0 | 9.93 | 73,779.9 | 1,803,968.0 | View | |
| Jan 07, 2026 | Chief Executive Officer | M | A | 14,250.0 | 0.0 | 0.0 | 1,811,398.0 | View | |
| Jan 07, 2026 | Chief Scientific Officer | M | D | 4,750.0 | 0.0 | 0.0 | 9,500.0 | View | |
| Jan 07, 2026 | Chief Scientific Officer | F | D | 2,381.0 | 9.93 | 23,643.33 | 7,715.0 | View | |
| Jan 07, 2026 | Chief Scientific Officer | M | A | 4,750.0 | 0.0 | 0.0 | 10,096.0 | View | |
| Nov 18, 2025 | VP, Chief Accounting Officer | P | A | 17,000.0 | 8.5159 | 144,770.3 | 20,000.0 | View | |
| Nov 17, 2025 | — | P | A | 3,333,333.0 | 7.5 | 24,999,997.5 | 5,653,904.0 | View | |
| Nov 17, 2025 | — | P | A | 400,000.0 | 7.5 | 3,000,000.0 | 2,020,071.0 | View | |
| Nov 17, 2025 | Chief Executive Officer | P | A | 333,333.0 | 7.5 | 2,499,997.5 | 740,546.0 | View | |
| Nov 17, 2025 | Chief Executive Officer | P | A | 333,333.0 | 7.5 | 2,499,997.5 | 1,195,275.0 | View |